J.P. Morgan analyst Jessica Fye maintained a Buy rating on Ascendis Pharma (ASND – Research Report) today and set a price target of $167.00.

T he staff of Pitchfork listens to a lot of new music. A lot of it. On any given day our writers, editors, and contributors ...

KUALA LUMPUR, MALAYSIA / ACCESS Newswire / January 27, 2025 / KUALA LUMPUR - ES Sunlogy Berhad ("ES Sunlogy" or the "Company"), an established provider of mechanical and electrical ("M&E") engineering ...

Since the previous release, there has been a methodological update to how private pension wealth ... Household wealth was distributed considerably more unequally than household income. For the ...

GameSpot may get a commission from retail offers. There's nothing quite like Doom, especially after recent releases saw the series reinvent itself as a fast-paced arcade-shooter that wasn't afraid ...

“His mother has been protesting and made several demands for his release,” the Taliban leader said. The Taliban leader, who said he has participated in some of the meetings with U.S ...

Notably, RichTech's proven track record is evident in its impressive gross profit margin growth from 97.09% in FYE 2021 to 98.17% in FYE 2023, demonstrating its ability to scale efficiently while ...

We've also included a section with rumoured releases. Here is every game that's been teased for Switch 2 but remains confirmed at the moment. We're not including games that leakers and industry ...

6 OTT releases to watch this week: From new seasons of old shows to fresh new releases, this week's digital releases have something for everyone. 6 OTT releases to watch this week: New seasons of ...